Keywords
Lisch nodules
neurofibromatosis
Von Recklinghausen disease
How to Cite
Abstract
Introduction :
Neurofibromatosis type 1 is an autosomal dominant disease with cutaneous and neurological manifestations being the most frequent. Ocular manifestations are rarer. The aim of this study was to report a case of neurofibromatosis type 1 with an ocular manifestation diagnose in Niger.
Observation :
This was a 33-year-old patient, clinical examination revealed multiple bilateral Lish nodules associated with milk coffee spots and neurofibromas, confirming the diagnosis. Management consisted of therapeutic abstinence and regular monitoring.
Conclusion :
Neurofibromatosis type 1 is a systemic disease, the ophthalmologist plays a crucial role in the diagnosis in the search for the Lisch nodule and rarely for the glioma of the optic pathways.
References
1. Ly KI, Blakeley JO. The Diagnosis and Management of Neurofibromatosis Type 1. Med Clin North Am. 2019 Nov;103(6):1035-1054. doi: 10.1016/j.mcna.2019.07.004. PMID: 31582003.
2. Wolkenstein P, Zeller J et Ismaïli N. Neurofibromatoses. Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris. Dermatologie, 98-755-A-10, 2002, 10 p.
3. Ferner R. Neurofibromatosis 1. Eur J Hum Genet 2007; 15(1):131-8.
4. [4]. Wilson BN, John AM, Handler MZ, Schwartz RA. Neurofibromatosis type 1: New developments in genetics and treatment. J Am Acad Dermatol. 2021; 84(6):1667-1676. doi: 10.1016/j.jaad.2020.07.105. Epub 2020 Aug 6. PMID: 32771543.
5. Merlán Hermida A, Aroza Espinar M, Puente Fernández A. Neurofibromatosis type 1 (von Recklinghausen's disease). Med Clin (Barc). 2019 Oct 25;153(8):e44. English, Spanish. doi: 10.1016/j.medcli.2019.04.006. Epub 2019 Jun 4. PMID: 31171350.
6. Laminou, L., Kadidia, I.K., Adam, N.D., Kaka, Y.A. and Abdou, A. (2022) Neurofibromatosis Type 1: About a Series of 5 Cases. Open Journal of Ophthalmology, 12, 407-415. https://doi.org/10.4236/ojoph.2022.12403
7. Daou, M., Sidibé, H., Andia, A., Araoye, M.J.Y., Konaté, M., Mamadou, Z., Kaka, Y.A., Bako, D.I., Beydou, S., Brah, S., Salissou, L., Adehossi, E. and Sanoussi, S. (2021) Neurofibromatosis Type 1 or Von Recklinghausen Disease: About Three Cases to the National Hospital of Niamey and Literature Review. Open Journal of Internal Medicine, 11, 175-187. https://doi.org/10.4236/ojim.2021.113013.
8. Bahuau M, Vidaud M, Vidaud D. Neurofibromatose. Génétique et physiopathologie moléculaire de la NF1. Méd/Thér 1997 ; 3 ; 623-628
9. Burnei G, Vlad C, Georgescu I, Gavriliu S, Dan D, Vlad AM. Von Recklinghausen's disease-elements of clinical practice. Rom J Intern Med. 2006;44(4):377-87. PMID: 18386614.
10. Alae El Bouaychi et al. Neurofibromatose type 1 : à propos d´un cas. PAMJ Clinical Medicine. 2020;4(101). 10.11604/pamj-cm.2020.4.101.23899
11. Kawtar Bouirig et al. Nodules de Lisch: marqueur ophtalmologique de la neurofibromatose de type 1. Pan African Medical Journal. 2022;42(108). 10.11604/pamj.2022.42.108.35079
12. Kehrer-Sawatzki H, Cooper DN. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants. Hum Genet. 2022 Feb;141(2):177-191. doi: 10.1007/s00439-021-02410-z. Epub 2021 Dec 20. PMID: 34928431; PMCID: PMC8807470.
13. Kinori M, Hodgson N, Zeid JL. Ophthalmic manifestations in neurofibromatosis type 1. Surv Ophthalmol. 2018 Jul-Aug;63(4):518-533. doi: 10.1016/j.survophthal.2017.10.007. Epub 2017 Nov 16. PMID: 29080631.
14. Vidaud, D., Levy, P., Laurendeau, I., Parfait, B., Bieche, I. et Vidaud, M. (2008) Approche moléculaire des MPNSTs dans la neurofibromatose de type 1: Vers l’identification de marqueurs diagnostiques et pronostiques. Archives de Pédiatrie, 15, 809-811.
Metrics
Downloads
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 A Youssoufou Souley, A Nouhou Diori, L Laminou, M Aboubacar Abdou, A Amza